Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Allicin, a compound derived from garlic (Allium sativum), has been investigated for its cardiovascular benefits, including the potential to prevent blood clot formation (antithrombotic effect). Several in vitro and animal studies suggest that allicin and other sulfur-containing compounds in garlic can inhibit platelet aggregation, which is a key step in the formation of blood clots. This effect is believed to occur through mechanisms such as increasing nitric oxide production, inhibiting thromboxane formation, and affecting calcium signaling in platelets. Some small human clinical trials have also reported reduced platelet aggregation in individuals consuming garlic supplements, though results are inconsistent and often use varied preparations and dosages.

Despite these promising findings, the overall quality and size of human studies remain limited. Most clinical trials are small, short in duration, and sometimes lack rigorous controls. Major medical guidelines do not currently recommend allicin or garlic supplementation as a primary method for preventing blood clots, and it should not be considered a substitute for established antithrombotic medications. Nonetheless, the traditional use of garlic for cardiovascular health does have some scientific backing, and there is modest evidence to suggest allicin may have a mild blood-thinning effect. Overall, the scientific evidence is preliminary and rated as 2 out of 5 for this use.

More about Allicin
More about Blood Clots (prevention of)

Other ingredients used for Blood Clots (prevention of)

Other health conditions supported by Allicin

Products containing Allicin